|
WO2018005332A1
|
|
Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof
|
|
US2014057735A1
|
|
Scientific golf and equipment
|
|
MX2014008191A
|
|
N-acylpeptide derivatives and their uses.
|
|
EP1998788A2
|
|
Composition and method for topical treatment of tar-responsive dermatological disorders
|
|
US2007093551A1
|
|
Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites
|
|
US2006251597A1
|
|
Anti-odor compositions and therapeutic use
|
|
US2006211754A1
|
|
Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
|
|
WO2006084174A2
|
|
Improved bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
CN101128117A
|
|
Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
|
|
US2006166901A1
|
|
Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
|
|
US2006063827A1
|
|
Systemic administration of therapeutic amino acids and N-acetylamino acids
|
|
US7452545B2
|
|
Oligosaccharide aldonic acids and their topical use
|
|
US2004220264A1
|
|
Bioavailability and improved delivery of acidic pharmaceutical drugs
|
|
WO2004080468A1
|
|
Improved bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
WO2004089329A2
|
|
Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
|
|
US2004147452A1
|
|
Non-amphoteric glutathione derivative compositions for tropical application
|
|
CA2468256A1
|
|
Compositions comprising phenyl-glycine derivatives
|
|
AU6335300A
|
|
Oligosaccharide aldonic acids and their topical use
|
|
EP1685843A1
|
|
Oligosaccharide aldonic acids and their topical use
|
|
CA2778317A1
|
|
Topical composition comprising n-acetylaldosamines or n-acetylamino acids
|
